These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30538838)

  • 1. Effect of VEGFR, PDGFR and PI3K/mTOR Targeting in Glioblastoma.
    Purcaru SO; Tache DE; Serban F; Folcuti RM; Georgescu AM; Stovicek PO; Danciulescu MM; Tataranu LG; Dricu A
    Curr Health Sci J; 2015; 41(4):325-332. PubMed ID: 30538838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
    Serban F; Daianu O; Tataranu LG; Artene SA; Emami G; Georgescu AM; Alexandru O; Purcaru SO; Tache DE; Danciulescu MM; Sfredel V; Dricu A
    J Immunoassay Immunochem; 2017; 38(1):21-33. PubMed ID: 27379831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.
    Popescu AM; Alexandru O; Brindusa C; Purcaru SO; Tache DE; Tataranu LG; Taisescu C; Dricu A
    Int J Clin Exp Pathol; 2015; 8(7):7825-37. PubMed ID: 26339347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
    Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells.
    Nanta R; Shrivastava A; Sharma J; Shankar S; Srivastava RK
    Mol Cell Biochem; 2019 Apr; 454(1-2):11-23. PubMed ID: 30251117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
    Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
    Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
    J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
    Li X; Wu C; Chen N; Gu H; Yen A; Cao L; Wang E; Wang L
    Oncotarget; 2016 May; 7(22):33440-50. PubMed ID: 26967052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget inhibitors derived from crosstalk mechanism involving VEGFR2.
    Ding C; Zhang C; Zhang M; Chen YZ; Tan C; Tan Y; Jiang Y
    Future Med Chem; 2014; 6(16):1771-89. PubMed ID: 25407368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
    Maiti P; Plemmons A; Dunbar GL
    PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
    Saini KS; Loi S; de Azambuja E; Metzger-Filho O; Saini ML; Ignatiadis M; Dancey JE; Piccart-Gebhart MJ
    Cancer Treat Rev; 2013 Dec; 39(8):935-46. PubMed ID: 23643661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.
    Song K; Yuan Y; Lin Y; Wang YX; Zhou J; Gai QJ; Zhang L; Mao M; Yao XX; Qin Y; Lu HM; Zhang X; Cui YH; Bian XW; Zhang X; Wang Y
    Am J Cancer Res; 2018; 8(5):792-809. PubMed ID: 29888103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
    Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
    Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.
    Alexandru O; Horescu C; Sevastre AS; Cioc CE; Baloi C; Oprita A; Dricu A
    Contemp Oncol (Pozn); 2020; 24(1):55-66. PubMed ID: 32514239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
    Kuger S; Flentje M; Djuzenova CS
    Radiat Oncol; 2015 Oct; 10():214. PubMed ID: 26498922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma
    Yu CC; Hung SK; Lin HY; Chiou WY; Lee MS; Liao HF; Huang HB; Ho HC; Su YC
    Oncotarget; 2017 Sep; 8(40):68641-68653. PubMed ID: 28978144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy.
    Vehlow A; Cordes N
    Autophagy; 2019 Aug; 15(8):1487-1488. PubMed ID: 31117874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.